Entera Bio Ltd. — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2023-01-02

Reporting Person: LIEBERMAN GERALD M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-02	Stock Option (right to buy)	$0.73	A	89041	Acquired	2033-01-02	Ordinary Shares, par value NIS 0.0000769 per share (89041)	Direct

Footnotes

F1: The options vest ratably on a quarterly basis over a one-year period that commenced on January 2, 2023.